Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | CA2 | P00918 | 4/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | EGFR | P00533 | 2/20 | 0.67 |
| ▸ | FYN | P06241 | 2/20 | 0.67 |
| ▸ | MMP9 | P14780 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | NPC1 | O15118 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | CA4 | P22748 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | CA12 | O43570 | 1/20 | 0.67 |
| ▸ | GMNN | O75496 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Catechol SCHEMBL7569845 | 0.90 | CA2 (0.71) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Catechol SCHEMBL11566875 | 0.90 | CA2 (0.71) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Catechol SCHEMBL27754508 | 0.88 | ALDH1A1 (0.59) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Catechol SCHEMBL2581350 | 0.87 | ALDH1A1 (0.67) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Pentadecane SCHEMBL27500799 | 0.85 | ALDH1A1 (0.56) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Catechol SCHEMBL27792619 | 0.85 | TDP1 (0.56) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Catechol SCHEMBL27517238 | 0.85 | ALDH1A1 (0.56) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Octane SCHEMBL27871796 | 0.85 | ALDH1A1 (0.56) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Catechol SCHEMBL23241892 | 0.84 | ALDH1A1 (0.62) | ALDH1A1CA2TDP1ALOX15LMNA | |
| Catechol SCHEMBL6658686 | 0.84 | CA2 (0.62) | ALDH1A1CA2TDP1ALOX15LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102186503-A | Stable aqueous formulations of water insoluble or poorly soluble drugs | ERIMOS PHARMACEUTICALS LLC | 2011-09-14 | — | — | CN | claimed |
| CN-101389319-A | Methods of treating influenza viral infections | ERIMOS PHARMACEUTICALS LLC (US) | 2009-03-18 | — | — | CN | claimed |
| CN-101150955-A | Oral formulations for delivery of catecholic butanes including NDGA compounds | ERIMOS PHARMACEUTICALS LLC (US) | 2008-03-26 | — | — | CN | claimed |
| CN-101150956-A | Formulations for injection of catecholic butanes, including NDGA compounds, into animals | ERIMOS PHARMACEUTICALS LLC (US) | 2008-03-26 | — | — | CN | claimed |
| CN-1852705-A | Methods and compositions for delivery of catecholic butanes for treatment of obesity | ERIMOS PHARMACEUTICAL LLP (US) | 2006-10-25 | — | — | CN | claimed |
| CN-1849115-A | Methods and compositions for delivery of catecholic butanes for treatment of tumors | UNIV JOHNS HOPKINS (US) | 2006-10-18 | — | — | CN | claimed |
| CN-1838948-A | Methods and compositions for delivery of catecholic butanes for treatment of diseases | ERIMOS PHARMACEUTICAL LLP (US) | 2006-09-27 | — | — | CN | claimed |
| US-5928654-A | Modulating body/cranial hair growth with lipoxygenase/cyclooxygenase inhibitors | SOCIETE L'OREAL S.A. (FR) | 1999-07-27 | — | — | US | claimed |
| US-4880637-A | ALCOHOLS, ETHERS OR ESTERS, AS ANTITUMOR AGENTS, SKIN DISORDERS | CHEMEX PHARMACEUTICALS, INC. (US) | 1989-11-14 | — | — | US | claimed |
| EP-0288534-A4 | COMPOSITIONS OF CATECHOLIC BUTANES WITH ZINC. | CHEMEX PHARMACEUTICALS INC (US) | 1989-02-23 | — | — | EP | claimed |
| EP-0288534-A1 | COMPOSITIONS OF CATECHOLIC BUTANES WITH ZINC. | CHEMEX PHARMACEUTICALS INC (US) | 1988-11-02 | — | — | EP | claimed |
| WO-1988003026-A1 | COMPOSITIONS OF CATECHOLIC BUTANES WITH ZINC | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-05-05 | — | — | WO | claimed |
| US-12037405-B2 | Anti-CD70 antibody drug conjugates | AMBRX, INC. | 2024-07-16 | — | — | US | disclosed |
| US-20240190981-A1 | Humanized Anti-CD70 Binding Agents and Uses Thereof | SEAGEN INC (US) | 2024-06-13 | — | — | US | disclosed |
| US-20240182580-A1 | ANTI-CD74 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI CD74 ANTIBODY CONJUGATES AND METHODS OF USING ANTI-CD74 ANTIBODY CONJUGATES | SUTRO BIOPHARMA INC (US) | 2024-06-06 | — | — | US | disclosed |
| WO-2024091979-A1 | CD276 (B7-H3) ANTIBODY-DRUG CONJUGATES | BRICKBIO, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| US-5928654-A | Modulating body/cranial hair growth with lipoxygenase/cyclooxygenase inhibitors | SOCIETE L'OREAL S.A. (FR) | 1999-07-27 | — | — | US | disclosed |
| EP-0288534-B1 | COMPOSITIONS OF CATECHOLIC BUTANES WITH ZINC | CHEMEX PHARMACEUTICALS, INC. (US) | 1991-12-18 | — | — | EP | disclosed |
| JP-S6479112-A | TREATMENT OF TUMOR BY CATECHOL BUTANE COMPOSITION | KEMETSUKUSU PHARMACEUT INC | 1989-03-24 | — | — | JP | disclosed |
| US-3970640-A | Process for the production of polyphenylene ethers having a desired polymerization degree | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JA) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037405-B2 | Anti-CD70 antibody drug conjugates | CD74, CD63, CD47 | ALDH1A1 868/4885CA2 3077/4885TDP1 3783/4885 |
| US-20240182580-A1 | ANTI-CD74 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI CD74 ANTIBODY CONJUGATES AND METHODS OF USING ANTI-CD74 ANTIBODY CONJUGATES | CD74, CD63, CD99 | ALDH1A1 1241/4885CA2 2152/4885TDP1 3110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.